Pfizer Inc.: Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older
FDA also authorizes second booster dose for individuals 12 years of age and older who have certain kinds of immunocompromise Second booster dose is intended to offer increased protection against